Therapy-related Myeloid Neoplasms in Patients with Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy

Kamel Laribi; Alix Baugier De Materre; David Ghez; Caroline Dartigeas; Cécile Tomowiak; Béatrice Mahé; Jean Baptiste Micol; Fatiha Merabet; Stéphane Leprêtre; Charles Herbaux; Loïc Ysebaert; Ronan Le Calloch; Lise Willems; Maud Voldoire; Damien Roos-Weil; Clotilde Bravetti; Yamina Touileb; Frédéric Davi; Florence Nguyen-Khac; Karim Maloum; Marie C. Béné

doi:10.1097/HS9.0000000000000716

Therapy-related Myeloid Neoplasms in Patients with Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy

Kamel Laribi, Alix Baugier De Materre, David Ghez, Caroline Dartigeas, Cécile Tomowiak, Béatrice Mahé, Jean Baptiste Micol, Fatiha Merabet, Stéphane Leprêtre, Charles Herbaux, Loïc Ysebaert, Ronan Le Calloch, Lise Willems, Maud Voldoire, Damien Roos-Weil, Clotilde Bravetti, Yamina Touileb, Frédéric Davi, Florence Nguyen-Khac, Karim MaloumMarie C. Béné

Résultats de recherche: Contribution à un journal › Letter › Revue par des pairs

3 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	E716
journal	HemaSphere
Volume	6
Numéro de publication	6
Les DOIs	https://doi.org/10.1097/HS9.0000000000000716
état	Publié - 11 juin 2022
Modification externe	Oui

Accès au document

10.1097/HS9.0000000000000716

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

Laribi, K., Baugier De Materre, A., Ghez, D., Dartigeas, C., Tomowiak, C., Mahé, B., Micol, J. B., Merabet, F., Leprêtre, S., Herbaux, C., Ysebaert, L., Le Calloch, R., Willems, L., Voldoire, M., Roos-Weil, D., Bravetti, C., Touileb, Y., Davi, F., Nguyen-Khac, F., ... Béné, M. C. (2022). Therapy-related Myeloid Neoplasms in Patients with Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy. HemaSphere, 6(6), E716. https://doi.org/10.1097/HS9.0000000000000716

@article{39e89ae4aeb9457cb9c0a04aa4c3a908,

title = "Therapy-related Myeloid Neoplasms in Patients with Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy",

author = "Kamel Laribi and {Baugier De Materre}, Alix and David Ghez and Caroline Dartigeas and C{\'e}cile Tomowiak and B{\'e}atrice Mah{\'e} and Micol, {Jean Baptiste} and Fatiha Merabet and St{\'e}phane Lepr{\^e}tre and Charles Herbaux and Lo{\"i}c Ysebaert and {Le Calloch}, Ronan and Lise Willems and Maud Voldoire and Damien Roos-Weil and Clotilde Bravetti and Yamina Touileb and Fr{\'e}d{\'e}ric Davi and Florence Nguyen-Khac and Karim Maloum and B{\'e}n{\'e}, {Marie C.}",

note = "Funding Information: DG received honoraria from Janssen, Abbvie and Astra Zeneca, and research grant from Beigene outside the submitted work. J-BM received honoraria from Abbvie, Jazz Pharmaceuticals and Astellas outside the submitted work. Outside this study, KL received Grants from Novartis, Takeda, Jansen, Abbvie, and personal fees from Novartis, Takeda, Abbvie, Iqone, Astra Zeneca, and Beigene. All the other authors have no conflicts of interest to disclose.",

year = "2022",

month = jun,

day = "11",

doi = "10.1097/HS9.0000000000000716",

language = "English",

volume = "6",

pages = "E716",

journal = "HemaSphere",

issn = "2572-9241",

number = "6",

}

Laribi, K, Baugier De Materre, A, Ghez, D, Dartigeas, C, Tomowiak, C, Mahé, B, Micol, JB, Merabet, F, Leprêtre, S, Herbaux, C, Ysebaert, L, Le Calloch, R, Willems, L, Voldoire, M, Roos-Weil, D, Bravetti, C, Touileb, Y, Davi, F, Nguyen-Khac, F, Maloum, K & Béné, MC 2022, 'Therapy-related Myeloid Neoplasms in Patients with Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy', HemaSphere, VOL. 6, Numéro 6, p. E716. https://doi.org/10.1097/HS9.0000000000000716

TY - JOUR

T1 - Therapy-related Myeloid Neoplasms in Patients with Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy

AU - Laribi, Kamel

AU - Baugier De Materre, Alix

AU - Ghez, David

AU - Dartigeas, Caroline

AU - Tomowiak, Cécile

AU - Mahé, Béatrice

AU - Micol, Jean Baptiste

AU - Merabet, Fatiha

AU - Leprêtre, Stéphane

AU - Herbaux, Charles

AU - Ysebaert, Loïc

AU - Le Calloch, Ronan

AU - Willems, Lise

AU - Voldoire, Maud

AU - Roos-Weil, Damien

AU - Bravetti, Clotilde

AU - Touileb, Yamina

AU - Davi, Frédéric

AU - Nguyen-Khac, Florence

AU - Maloum, Karim

AU - Béné, Marie C.

N1 - Funding Information: DG received honoraria from Janssen, Abbvie and Astra Zeneca, and research grant from Beigene outside the submitted work. J-BM received honoraria from Abbvie, Jazz Pharmaceuticals and Astellas outside the submitted work. Outside this study, KL received Grants from Novartis, Takeda, Jansen, Abbvie, and personal fees from Novartis, Takeda, Abbvie, Iqone, Astra Zeneca, and Beigene. All the other authors have no conflicts of interest to disclose.

PY - 2022/6/11

Y1 - 2022/6/11

UR - http://www.scopus.com/inward/record.url?scp=85130989324&partnerID=8YFLogxK

U2 - 10.1097/HS9.0000000000000716

DO - 10.1097/HS9.0000000000000716

M3 - Letter

AN - SCOPUS:85130989324

SN - 2572-9241

VL - 6

SP - E716

JO - HemaSphere

JF - HemaSphere

IS - 6

ER -